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Background: Human T-cell leukemia virus type 1 (HTLV-1) causes chronic infection leading to development of
adult T-cell leukemia (ATL) and inflammatory diseases. Non-human primates infected with simian T-cell leukemia
virus type 1 (STLV-1) are considered to constitute a suitable animal model for HTLV-1 research. However, the
function of the regulatory and accessory genes of STLV-1 has not been analyzed in detail. In this study, STLV-1 in
naturally infected Japanese macaques was analyzed.
Results: We identified spliced transcripts of STLV-1 corresponding to HTLV-1 tax and HTLV-1 bZIP factor (HBZ).
STLV-1 Tax activated the NFAT, AP-1 and NF-κB signaling pathways, whereas STLV-1 bZIP factor (SBZ) suppressed
them. Conversely, SBZ enhanced TGF-β signaling and induced Foxp3 expression. Furthermore, STLV-1 Tax activated
the canonical Wnt pathway while SBZ suppressed it. STLV-1 Tax enhanced the viral promoter activity while SBZ
suppressed its activation. Then we addressed the clonal proliferation of STLV-1+ cells by massively sequencing the
provirus integration sites. Some clones proliferated distinctively in monkeys with higher STLV-1 proviral loads.
Notably, one of the monkeys surveyed in this study developed T-cell lymphoma in the brain; STLV-1 provirus was
integrated in the lymphoma cell genome. When anti-CCR4 antibody, mogamulizumab, was administered into STLV-
1-infected monkeys, the proviral load decreased dramatically within 2 weeks. We observed that some abundant
clones recovered after discontinuation of mogamulizumab administration.
Conclusions: STLV-1 Tax and SBZ have functions similar to those of their counterparts in HTLV-1. This study
demonstrates that Japanese macaques naturally infected with STLV-1 resemble HTLV-1 carriers and are a suitable
model for the investigation of persistent HTLV-1 infection and asymptomatic HTLV-1 carrier state. Using these
animals, we verified that mogamulizumab, which is currently used as a drug for relapsed ATL, is also effective in
reducing the proviral load in asymptomatic individuals.
Keywords: Simian T-cell leukemia virus, Human T-cell leukemia virus, Tax, HBZBackground
Human T-cell leukemia virus type 1 (HTLV-1) was the first
human retrovirus found to cause a neoplastic disease, adult
T-cell leukemia (ATL) [1,2]. Approximately 10 million
people worldwide are estimated to be infected with this
virus. HTLV-1 is endemic in specific areas including south-
western Japan, Central and South America, the Caribbean,* Correspondence: mmatsuok@virus.kyoto-u.ac.jp
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reproduction in any medium, provided the orand intertropical Africa [3]. Most HTLV-1 carriers remain
asymptomatic through their lives and only a small fraction
of them develop ATL, a leukemia of HTLV-1-infected
CD4+ T cells, after a long latent period [4]. This virus also
causes inflammatory disorders such as HTLV-1-associated
myelopathy/tropic spastic paraparesis (HAM/TSP) [5,6]
and uveitis [7].
The reason why most HTLV-1 carriers do not develop
ATL is partly explained by the immune response of cyto-
toxic T cells (CTLs) against HTLV-1 proteins [8]. Immuno-
suppressive conditions, particularly following organ or bonetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ATL [9,10], indicating that the host immune system usually
prevents the development of ATL. Two HTLV-1 proteins,
Tax and HTLV-1 bZIP factor (HBZ), are thought to pro-
mote the proliferation of infected cells and ATL cells [4,11].
Tax is highly immunogenic to CTLs and the infected cells
expressing Tax are kept to a small number [12]. Recently, it
has been reported that CTLs to HBZ play a critical role in
determining proviral load in carriers [13].
Animal models that are relevant to the human immune
system are required for scientists to investigate how the im-
mune response controls the proliferation of infected cells
and viral replication in vivo. Old World monkeys are fre-
quently infected with simian T-cell leukemia virus type 1
(STLV-1), which is closely related to HTLV-1 [14]. Like
HTLV-1 infection, clonal proliferation of STLV-1-infected
cells was detected by inverse PCR [15]. Furthermore,
STLV-1 also leads to the development of lymphoprolifera-
tive diseases [16,17]. Based on these observations, it has
been proposed that STLV-1-infected non-human primates
may constitute a suitable animal model for HTLV-1 re-
search. However, a detailed characterization of STLV-1 in-
fection in non-human primates has not been achieved.
In the present study, Japanese macaques naturally in-
fected with STLV-1 were investigated. We first identified
the STLV-1 bZIP factor (SBZ) gene as an antisense tran-
script of STLV-1 similar to HBZ. Molecular analyses
showed that STLV-1 Tax and SBZ have activities on
various transcriptional pathways similar to those of
HTLV-1 Tax and HBZ. Furthermore, we observed clonal
proliferation of STLV-1-infected cells. Finally, anti-CCR4
antibody, which is currently used to treat ATL patients,
was administered into STLV-1-infected Japanese ma-
caques, and we found that this reduced the proviral load
in vivo, indicating that anti-CCR4 antibody is effective
for treatment of HTLV-1-associated inflammatory dis-
eases. These results suggest that Japanese macaques nat-
urally infected with STLV-1 show characteristics that
correlate closely with those of HTLV-1 carriers and may
therefore serve as a suitable animal model for the ana-
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Figure 1 STLV-1 infection in Japanese and rhesus macaques. (A) STLV
in this study is shown. (B) STLV-1 proviral load (percentage) in white bloodResults
Seroprevalence and proviral load of STLV-1 in Japanese
macaques
To identify STLV-1-infected monkeys, we screened
plasma samples for antibody against viral STLV-1 anti-
gens by particle-agglutination test. Out of 533 Japanese
macaques examined, 320 (60%) were seropositive, while
only one rhesus macaque out of 163 (0.6%) was sero-
positive (Figure 1A). Proviral load in white blood
cells was measured by quantitative real-time PCR for
115 seropositive Japanese macaques. Proviral load
ranged from 0.001% to over 10% (Figure 1B). Since
the DNA samples used in the above experiment were
obtained from total white blood cells including gran-
ulocytes, these data likely underestimate proviral load
of PBMCs.
Functional similarity of STLV-1 Tax and STLV-1 bZIP factor
to their counterparts in HTLV-1
Analysis of the STLV-1 pX region suggests the presence of
tax coding gene and an antisense transcript in the minus
strand of STLV-1 similar to HBZ. In order to examine if
STLV-1 tax and SBZ genes are transcribed and processed
to be mature mRNAs in STLV-1-infected PBMCs, STLV-1
tax and SBZ transcripts were amplified by RT-PCR using
the primers flanking the putative splicing site (Figure 2).
The length of the amplified fragments was comparable to
that of the corresponding HTLV-1 transcripts, which are
approximately 240 bp for tax and 310 bp for HBZ. We fur-
ther verified that STLV-1 tax and SBZ transcripts are
spliced at exactly the same location as HTLV-1 tax and
spliced form of HBZ [11,18], respectively (Figure 2). To in-
vestigate the molecular functions of STLV-1 Tax and SBZ,
we cloned the coding sequences of those proteins from the
STLV-1 provirus in a Japanese macaque (Mf-5). Approxi-
mately 91% of the coding sequence of tax was identical in
HTLV-1 (ATK) and Japanese macaque STLV-1, and 82% in
HBZ (ATK) and Japanese macaque SBZ. Phylogenetic ana-
lyses show that Japanese macaque STLV-1 env in this study
is close to Melanesian subtype C [5] (Additional file 1).
Therefore, the STLV-1 protein sequences were aligned with




















-1 seropositivity in Japanese macaques and rhesus macaques screened
cells of Japanese macaques is shown.
HTLV-1 (ATK) ---CCAAAGAAAAAGACCTCCAACACCATGGgtaagt
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STLV-1 bZIP factor ---TCCCTTGTCCATTTGTAGCTTTGCCGGgatgtg














Figure 2 Detection of STLV-1 tax and STLV-1 bZIP factor (SBZ) transcripts and their splicing junctions. STLV-1 tax and SBZ transcripts were
amplified by RT-PCR using the primers flanking the putative splicing site. The bands of the amplified fragments are shown together with the
corresponding transcript of HTLV-1 in the images of agarose gel stained with ethidium bromide. Numbers in the scheme indicate the nucleotide
positions of HTLV-1 ATK provirus. Sequences of the amplified STLV-1 tax and SBZ transcripts are represented with uppercase letters and aligned
with a reference sequence of HTLV-1 (ATK). The lowercase letters represent the intron region of HTLV-1 or STLV-1 provirus.
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proximately 93% of the STLV-1 Tax amino acid sequence
was identical to that of HTLV-1 Tax (Figure 3A) and ap-
proximately 73% of the amino acid sequence of SBZ was
identical to that of HBZ (Figure 3B). Notably, SBZ hasA
B
10        20        30        40
STLV-1  Mf-5: MAASGPFRCLPVPCPEDLLVDDLVDGLLSLEEDLNKQRTE
HTLV-1a ATK : .....L......S.......EE..........E.KD-.E.
HTLV-1c Mel5: ....................E..........DE.KD..E.
100       110       120       130
STLV-1  Mf-5: EREKEEEEQIAEFLRKKEEKKARRRRREEEKAAYRARRKR
HTLV-1a ATK : .......K.T.........E.......A.K...DV....Q
HTLV-1c Mel5: .......K.........R..E.W....A.....D.....L
190       200       210
STLV-1  Mf-5: AERKRLLQEKEDLMGEVNYWQGRLQAMWSQ
HTLV-1a ATK : ............................L.
HTLV-1c Mel5: ...G.....ND..........R........
10        20        30        40
STLV-1  Mf-5: MAHFPGFGQSLLYGYPVYVFGDCVQGDWCPISGGLCSARL
HTLV-1a ATK : ........................................
HTLV-1c Mel5: ........................................
100       110       120       130
STLV-1  Mf-5: TPPATHTTPNIPPSFFQAVRKYSPFRNGYMEPTLGQQLPT
HTLV-1a ATK : ...I...........L....................H...
HTLV-1c Mel5: ...T................QH......C...........
190       200       210       220
STLV-1  Mf-5: AFLTNVPYKRMEELLYKIFLNTGATIILPEDCLPTTLFQP
HTLV-1a ATK : ..................S.T...L...............
HTLV-1c Mel5: ........................L.....G.........
280       290       300       310
STLV-1  Mf-5: LQSSSFIFHKFQTKAYHPSFLLSHGLIQYSSFHNLHLLFE
HTLV-1a ATK : .................................S......
HTLV-1c Mel5: ...................V.............S...P..
Figure 3 Comparison of the amino acid sequences of STLV-1 Tax and
STLV-1 Tax (A) and SBZ (B) derived from an STLV-1+ Japanese macaque (M
two isolates. Asterisk represents the termination codon. Accession number:some insertions and deletions, resulting in an excess of
three amino acids compared with HBZ.
It was previously shown that HTLV-1 Tax activates the
NF-κB, NFAT and AP-1 pathways [19,20], whereas HBZ
























SBZ with those of HTLV-1 Tax and HBZ. Amino acid sequences of
f-5) are compared respectively with those of HTLV-1 Tax and HBZ from
[GenBank:J02029] (ATK) and [GenBank:L02534] (Mel5).
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that, like HTLV-1 Tax, STLV-1 Tax activated these path-
ways (Figure 4A). Conversely, SBZ suppressed these
pathways when they were activated by phorbol myristate
acetate and ionomycin (NFAT and AP-1) or HTLV-1
Tax (NF-κB) (Figure 4B).
Recently, our group reported that HBZ enhances TGF-β
signaling via interaction with Smad2/3 and p300, thus indu-
cing the expression of Foxp3 in vitro [22]. The analysis of
HBZ transgenic mice further demonstrated an increase in
Foxp3+ T cells [23]. Therefore, we investigated whether SBZ
also enhances TGF-β signaling. We found that SBZ en-
hanced signaling by the TGF-β pathway, while STLV-1 TaxFigure 4 Effects of STLV-1 Tax and SBZ on various signaling pathway
analyzed using reporter plasmids for the NFAT, AP-1 and NF-κB pathways i
or SBZ (right) on the TGF-β signaling pathway were analyzed in HepG2 cel
element to Smad3/4. (D) The effects of HTLV-1 Tax or STLV-1 Tax (left) and
responsive elements were analyzed using Jurkat cells. (E) The effects of HT
luciferase activity driven by viral LTR were analyzed using Jurkat cells. Firefl
represented as fold activation compared to the relevant control. The data rsuppressed it (Figure 4C). Like HBZ, expression of SBZ in
mouse naïve CD4+ T cells induced expression of Foxp3, and
this expression was significantly enhanced by TGF-β
(Figure 5). Thus, SBZ, like its counterpart HBZ, activates
the TGF-β/Smad pathway and induces Foxp3 expression in
CD4+ Tcells.
Next we studied STLV-1 Tax and SBZ for their capability
to regulate the canonical Wnt pathway in the manner we
recently reported for HTLV-1 Tax and HBZ [24]. STLV-1
Tax, like HTLV-1 Tax, elevated the activity of luciferase reg-
ulated by the promoter responsive to TCF/LEF in the pres-
ence of Dvl2 and DAPLE (Figure 4D). In contrast, when
SBZ was co-expressed with Tax, luciferase activity wass. Effects of HTLV-1 Tax or STLV-1 Tax (A), and HBZ or SBZ (B) were
n Jurkat cells. (C) The effects of HTLV-1 Tax or STLV-1 Tax (left) and HBZ
ls using the reporter plasmid 3TP-Lux, which contains the responsive
HBZ or SBZ (right) on relative luciferase activity driven by TCF-
LV-1 Tax or STLV-1 Tax (left) and HBZ or SBZ (right) on relative
y luciferase activity was normalized to that of Renilla luciferase and














Figure 5 Flow cytometric analyses of Foxp3 induction by SBZ. SBZ or HBZ transduced mouse T cells that were positive for the transduction
marker were analyzed for Foxp3 expression. The percentage of cells positive for Foxp3 is shown in each histogram. Each experiment was done at
least in triplicate, and representative results are shown.
Miura et al. Retrovirology 2013, 10:118 Page 5 of 12
http://www.retrovirology.com/content/10/1/118suppressed (Figure 4D). These results demonstrate that like
their counterparts in HTLV-1, STLV-1 Tax activates the ca-
nonical Wnt pathway while SBZ suppresses it.
Lastly, regulation of viral promoter activity by STLV-1
Tax and SBZ was examined since it is known that
HTLV-1 Tax activates the viral transcription from the 5’
long terminal repeat (LTR) of the provirus while HBZ
suppresses it. As presented in Figure 4E, STLV-1 Tax ac-
tivated transcription of WT-Luc while SBZ suppressed it
in Jurkat cells. It is consistent with functions of HTLV-1
Tax and HBZ.
Clonal proliferation of STLV-1-infected cells in Japanese
macaques
Clonal proliferation of HTLV-1-infected cells has been
demonstrated by inverse PCR and next generationsequencing methods [25-27]. We analyzed the clonality of
STLV-1-infected cells in seropositive Japanese macaques by
identifying the genomic sequences adjacent to the 3’ LTR.
Briefly, genomic DNAs of monkey PBMCs were sheared by
sonication and the integration sites of the provirus adjacent
to the viral 3’ LTR were amplified by linker-mediated PCR.
Thereafter, we massively sequenced the integration sites
and analyzed the abundance of each clones according to
the method reported by Gillet et al. [27]. The detailed
information on the deep sequencing is described in
Additional file 2. The clonality of STLV-1-infected cells in
three monkeys is shown in Figure 6A. Proviral load is rep-
resented as the percentage of STLV-1-infected cells in
PBMCs. In monkeys with lower proviral load, a few major
clones, together with many minor ones, were observed in
Mf-1. Some clones proliferated in Mf-2 (Figure 6A, left
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which had higher proviral load (17%), possessed two major
STLV-1-infected clones (Figure 6A, right). To study which
cell types are infected by STLV-1, Tax expression in
PBMCs obtained from one monkey (Mf-4) was analyzed
by flow cytometry. The Tax-expressing cells were largely
found to be CD4+ T cells, as is the case with HTLV-1 in-
fection in humans (Figure 6B).
STLV-1-associated T-cell lymphoma in a Japanese
macaque
A monkey (Mf-4) developed anorexia and had paralysis of
the lower limbs. This monkey had high proviral load (53%)
in PBMCs. We suspected that this monkey has devel-
oped a disease similar to HAM/TSP because paralysis
of the lower limbs is one of the major symptoms of
HAM/TSP patients. Magnetic resonance imaging (MRI)
revealed a high intensity lesion in the brain on a T2-
















Figure 6 Clonal proliferation of STLV-1-infected cells and lymphomat
relative frequency of STLV-1+ clones in three monkeys (Mf-1, Mf-2 and Mf-3
provirus in a separate clone (identified by its unique integration site). (B) Fl
shows that Tax-expressing cells are positive for CD4. (C) Magnetic resonanc
white arrow. (D) Immunohistochemical analyses show that lymphoma cells
clones identified by unique integration sites of the provirus in PBMCs (left)
that are observed both in PBMCs and the brain lesion are painted in the sa
40177103 is detected in the brain lesion by using the primers for 3’ LTR anthat this tumor was a lymphoma with atypical morphology,
and by immunohistochemical methods, it was found that
these cells were CD3+ CD4+ (Figure 6D). In contrast,
no obvious demyelination was observed in the spinal
cord. Thus, this monkey was diagnosed with T-cell
lymphoma in the brain rather than the disease like
HAM/TSP. In this monkey, some major clones had
proliferated in peripheral blood (Figure 6E, left). We
found that the major clones in peripheral blood were
also detected in the brain lesion (Figure 6E, right).
These observations demonstrate that STLV-1 causes
lymphoma in Japanese macaques. Notably, one of the
major clones in the brain, which had its provirus in-
tegration site in chromosome 13, was not detected in
PBMCs. This was confirmed by conventional PCR
using the primers for the 3’LTR and the host genome
proximal to the integration site (Figure 6F). Moreover, a
clone with the integration site in chromosome 18 was also














ous lesion in the STLV-1-infected Japanese macaque. (A) The
) is presented. Each area in the pie charts represents the proportion of
ow cytometric analysis of PBMCs from an STLV-1-infected monkey
e imaging of the brain of monkey Mf-4. The lesion is indicated by the
are positive for CD3 and CD4. (E) Relative abundance of STLV-1+
and in the brain lesion (right) of Mf-4. Some of the abundant clones
me color in the two pie charts. (F) STLV-1+ abundant clone 13[+]
d the genomic region, but not in PBMCs.
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formation of the tumor.
Treatment with anti-CCR4 antibody decreased proviral
load in STLV-1-infected Japanese macaques
ATL cells express high levels of CC chemokine receptor
4 (CCR4) [28]. Recently, mogamulizumab, a humanized
IgG1 monoclonal antibody against CCR4 [29], was ap-
proved in Japan for the treatment of relapsed ATL pa-
tients. HTLV-1-infected cells of healthy carriers also
express CCR4, which indicates that mogamulizumab
likely reduces the proviral load in HTLV-1-infected
asymptomatic individuals [30]. High proviral load has
been reported to be associated with HAM/TSP, HTLV-1











































































Figure 7 Effect of anti-CCR4 antibody on STLV-1 dynamics in vivo. (A)
analyzed by flow cytometry. (B) Changes in STLV-1 proviral load in two mo
numbers of the five most abundant clones in 1,000,000 PBMCs at weeks 0,may potentially be used for the treatment of HTLV-1-
associated diseases and the prevention of ATL. However,
it is not clear whether mogamulizumab can reduce the
proviral load in HTLV-1-infected individuals. We con-
firmed that mogamulizumab also recognizes macaque
CCR4 by staining Japanese macaque PBMCs in vitro
with the fluorescently labeled antibody (see Additional
file 3). Then, we tested the efficacy of mogamulizumab
to reduce the proviral load in STLV-1-infected Japanese
macaques. Mogamulizumab was administered to two
monkeys with high proviral load (Mf-6 and Mf-7), once
a week for 4 weeks. As shown in Figure 7A, nearly half
of the CD4+ T cells expressed CCR4 before the treat-
ment (week 0). After the treatment, the CCR4 positivity













ek 2 week 3 week 5
CD3+CD4+ T cells were gated and the expression of CCR4 was
nkeys treated with anti-CCR4 antibody until week 3. (C) Absolute cell
5 and 18 are shown.
Miura et al. Retrovirology 2013, 10:118 Page 8 of 12
http://www.retrovirology.com/content/10/1/118measured proviral load over the course of the treatment
and found that it decreased dramatically within 2 weeks
(Figure 7B). Thus, this demonstrates that mogamulizu-
mab can indeed reduce the number of STLV-1-infected
cells in vivo.
Eight weeks after the final administration of mogamu-
lizumab, the proviral load started to recover (Figure 7B).
To investigate whether mogamulizumab influences the
clonality of STLV-1-infected cells, we evaluated the ab-
solute number of each clone by high-throughput se-
quencing of provirus integration sites. Figure 7C shows
changes of the five most abundant clones at weeks 0, 5
and 18. The major clones before the treatment (week 0)
recovered at week 18 (red lines in Figure 7C), while
some clones were present constantly during the treat-
ment (grey lines) or diminished after the treatment (blue
lines). Interestingly, some clones (green lines) that
emerged in a monkey after treatment were rare or even
not detected before treatment (Figure 7C).
Discussion
HTLV-1 is thought to originate from STLV-1. In STLV-1-
infected monkeys, investigators found clonal proliferation
of STLV-1-infected cells and the preferential infection of
CD4+ T cells by the virus [15,31]. Moreover, several groups
reported the development of lymphomas in STLV-1-
infected monkeys [16,17,32-35]. Monoclonal integration of
STLV-1 in the lymphoproliferative disease of African green
monkeys was detected by Southern blot [16,33], demon-
strating the direct causative role of STLV-1. Thus STLV-1-
infected non-human primates have been thought to be a
useful animal model for HTLV-1 research. The dynamics of
infected cells after treatment with histone deacetylase in-
hibitors and reverse transcriptase inhibitors has been ana-
lyzed in STLV-1-infected baboons, and it was found that
this combination significantly decreased proviral load in
treated animals [36]. However, there have been no detailed
studies on functions of STLV-1-encoded genes. Analyses of
the functions of its accessory and regulatory proteins are
necessary if we are to use STLV-1-infected monkeys as a
model of HTLV-1 infection. In the present study, we fo-
cused on Japanese macaques naturally infected with STLV-
1.
The amino acid sequence of STLV-1 Tax is closely hom-
ologous to that of HTLV-1 Tax, and this study demon-
strated that their functions on various transcriptional
pathways are similar as well. This study was the first to
identify SBZ as an antisense transcript of STLV-1 and a
homolog of HBZ. SBZ and HBZ share only approximately
73% identity at the amino acid level. Nevertheless, for all
the functions we examined, SBZ behaves similarly to HBZ.
In particular, SBZ expression could induce Foxp3 expres-
sion like HBZ expression does. This might be attributed to
the following reasons. First, the N-terminal region, as wellas the heptad repeats of hydrophobic amino acids in the
basic leucine zipper domain, are conserved between HBZ
and SBZ. This may allow SBZ to interact with and suppress
NF-κB, AP-1 and other transcription factors with basic leu-
cine zipper motifs [37,38]. Second, the LXXLL-like region
(Leu27, Leu28, Leu48 and Leu49), which is critical for the
interaction with p300 and Smad3 protein, is also conserved
between HBZ and SBZ [22,39]. Some lysine residues
present in HBZ are substituted with different amino acids
in Japanese macaque SBZ. This study showed that SBZ has
similar functions compared with HBZ, suggesting that
these lysine residues are not critical for their functions.
However, further studies are necessary for deep under-
standing of implication of these amino acid sequences.
HTLV-1 increases the number of infected cells by
clonal proliferation of infected cells, which likely facili-
tates cell-to-cell transmission of this virus. Clonal prolif-
eration of STLV-1-infected cells in Celebes macaques
was demonstrated by the conventional inverse PCR
method [15]. However, this technique could detect only
a limited population of the clones because of its limited
sensitivity or the stochastic amplification of the integra-
tion sites. In the present study, we investigated more
comprehensively the clonal proliferation of infected cells
in Japanese macaques naturally infected with STLV-1 by
massively sequencing the unique integration sites of the
provirus. The finding that STLV-1-infected cells prolifer-
ated clonally in the monkeys with higher proviral loads
resembles the finding for HTLV-1. Furthermore, one
monkey had lymphoma in the brain, showing that
STLV-1 induces lymphoma in Japanese macaques. Ana-
lyses of STLV-1 integration sites in this T-cell lymphoma
showed that one of the major clones in the brain was
unique to this tumor, suggesting that this clone played
an important role in the lymphomagenesis of this tumor.
This study also revealed a remarkable difference in
STLV-1 seroprevalence between Japanese macaques
(320/533: 60%) and rhesus macaques (1/163: 0.6%). Pre-
vious studies showed that the seroprevalence in rhesus
macaques was 25%, and that in Japanese macaques was
quite high [40-42]. Similarly, high seroprevalence was re-
ported in baboons [43]. Furthermore, many studies re-
ported the development of lymphoma in baboons
[17,44,45]. The high seroprevalence and the develop-
ment of lymphomas in Japanese macaques and baboons
may suggest a higher susceptibility of these species to
STLV-1 infection. Japanese macaques and baboons in-
fected with STLV-1 may be suitable models for HTLV-1
research.
In this study, we also demonstrated that mogamulizumab
strongly suppressed proviral load in STLV-1-infected Japa-
nese macaques. Proviral load was suppressed for 4 weeks
after the final administration of mogamulizumab, which
seems reasonable when considering that the half-life of the
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days as measured in a clinical trial [46]. Some STLV-1-
infected major clones recovered after the treatment, while
other clones were still suppressed or even not detected. In
HTLV-1-infected individuals, HTLV-1 proviral load is rela-
tively constant in the chronic phase, although some minor
clones fluctuate [25]. This study is the first to report that
most of the major clones recover after the withdrawal of
mogamulizumab. This observation suggests that the major
clones may have some growth advantages that allow them
to proliferate robustly in vivo. These growth advantages
may be due to the integration site of the provirus, accumu-
lation of genetic mutations, or epigenetic changes. The
population of some clones remained constant over the
course of the treatment. We speculate that these clones are
negative for CCR4 expression. High proviral load is associ-
ated with risk of ATL and inflammatory diseases. There-
fore, suppression of proviral load by mogamulizumab is a
possible treatment for HTLV-1-associated inflammatory
diseases such as HAM/TSP.
Conclusions
In summary, this study is the first to show that STLV-1
Tax and SBZ have activities similar to those of Tax and
HBZ, activities which likely induce clonal proliferation
and T-cell lymphoma in infected monkeys. STLV-1-
infected Japanese macaques appear to be a good model
for studying the effects of anti-viral drugs and the im-
munological aspects of HTLV-1 infection.
Methods
Biological samples of macaques
Japanese macaques (Macaca fuscata) and rhesus ma-
caques (Macaca mulatta) used in this study were reared
in the Primate Research Institute, Kyoto University.
Blood samples were obtained from the macaques (for
routine veterinary and microbiological examination)
under ketamine anesthesia. All animal studies were con-
ducted in accordance with the protocols of experimental
procedures that were approved (2011–095) by the Ani-
mal Welfare and Animal Care Committee of the Primate
Research Institute of Kyoto University, Inuyama, Japan.
Antibody screening and measurement of proviral load
Plasma samples were screened for the presence of anti-
bodies against HTLV-1 by particle-agglutination test
using SERODIA-HTLV-1 (Fujirebio). Proviral load was
measured by real-time PCR quantifying the copy num-
ber of tax and RAG1 as previously described [47].
Primers and probes are available in Additional file 4.
Detection of STLV-1 transcripts
Total RNA was extracted from STLV-1-infected Japanese
macaque cell line Si-2 [48] with Trizol (Invitrogen), thencDNA was synthesized with SuperScript III (Invitrogen)
using oligo dT primer. STLV-1 tax and SBZ was detected
by PCR using primers (see Additional file 4) from the
synthesized Si-2 cDNA: for STLV-1 tax, 2 min at 95°C,
followed by 35 cycles of 20 seconds at 95°C, 10 seconds
at 61°C, and 30 seconds at 72°C, and additional 5 min at
72°C; for SBZ, 2 min at 95°C, followed by 35 cycles of
20 seconds at 95°C, 10 seconds at 58°C, and 30 seconds
at 72°C, and additional 5 min at 72°C. For comparison,
HTLV-1 tax and HBZ were also amplified by PCR using
cDNA of HTLV-1-infected cell lines (MT-1 or MT-2)
with the same conditions. The primers used are shown in
Additional file 4.
Plasmids
The PathDetect pNFκB-Luc, pAP-1-Luc and pNFAT-
Luc plasmids were purchased from Stratagene. The
3TP-Lux, TopFlash reporter plasmids and WT-Luc were
described previously [22,49]. The coding sequences of
STLV-1 Tax and SBZ were amplified from STLV-1 pro-
virus using oligos (see Additional file 4) and cloned into
pME18Sneo to generate expression plasmids of STLV-1
Tax and SBZ. HTLV-1 tax was amplified using flanking
primers (see Additional file 4) from pCGTax [50] and
subcloned into pME18Sneo. The expression vector of
HBZ cloned into pME18Sneo was described previously
[11]. For the reporter assay, Jurkat cells or HepG2 cells
were co-transfected with the reporter plasmid and the
viral protein expression plasmids specified in each ex-
periment, as previously described [22,24,51]. The activity
of firefly luciferase was represented by normalizing to
that of Renilla luciferase.
Retroviral vectors
The SBZ coding fragment was inserted into pGCDNSamI/
N utilizing the NotI and SalI sites and SBZ-expressing
retroviral vector was prepared as described previously [22].
Transduction of primary T-cells with retroviral vectors
CD4+CD25- mouse T lymphocytes were stimulated and
transduced with SBZ-expressing retroviral vector as pre-
viously described [22]. Forty-eight hours after the trans-
duction, cells were harvested and analyzed by flow
cytometry.
Flow cytometry
Antibodies used in this study were as follows: anti-
human CD4 (OKT4), anti-Tax MI-73 [52], anti-mouse
CD4 (RM4-5), anti-human CD271 (NGFR) (C40-1457),
anti-mouse Foxp3 (FJK-16s), anti-human CD3 (SP34-2)
and anti-human CCR4 (1G1, which recognizes a differ-
ent epitope from that recognized by mogamulizumab).
Intracellular staining was performed as previously de-
scribed for Tax [52] and Foxp3 [22]. Cells were analyzed
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sciences) or BD FACSVerse with FACSuite software (BD
Biosciences).
Deep sequencing of provirus integration sites
The provirus integration sites in the Japanese macaque gen-
ome were amplified by linker-mediated PCR as previously
described [27], with some modifications. Japanese macaque
PBMC genomic DNA (3 μg) was sheared by sonication
with a Bioruptor UCD-200 TM to obtain DNA fragments
of approximately 200–500 bp. The ends of the DNA frag-
ments were repaired to generate blunt ends using 18 units
of T4 DNA polymerase, 5.3 units of DNA Klenow Polymer-
ase I and 18 units of T4 polynucleotide kinase (TOYOBO)
in T4 DNA ligase buffer (NEB) supplemented with 300 μM
each of dNTP (TAKARA Bio). Adenine nucleotides were
added to the blunt ends, and then linkers were ligated using
24 units of T4 DNA ligase (TOYOBO) in T4 DNA ligase
buffer (NEB) utilizing the overhang of one thymidine nu-
cleotide at the 3’ end of the linker. The linker was generated
by annealing two oligonucleotides (see Additional file 4).
The first round of PCR was performed with the primers,
STLV-1 Bio5 and Bio4. STLV-1 Bio5 anneals to the se-
quence within LTR of the STLV-1 provirus and Bio4 is the
sequence present in the linker (see Additional file 4). Then,
nested PCR was performed with the primers, Ion A-Bio7
and P1. In Ion A-Bio7, uppercase letters denote the se-
quence that anneals to the viral LTR downstream of STLV-
1 Bio5, whereas the sequence in lowercase letters repre-
sents a tag specific for the Ion Torrent Personal Genome
Machine (Ion PGM). P1 is also a tag specific for Ion PGM,
which appears in the linker sequence (see Additional file 4).
The amplification conditions of both the first and second
PCR were 96°C for 30 sec, 7 cycles of 94°C for 5 sec and
72°C for 1 min, 23 cycles of 94°C for 5 sec and 68°C for 1
min, followed by additional 68°C for 9 min. Amplified frag-
ments of approximately 150–300 bp were size-selected with
E-Gel SizeSelect Agarose Gel (Life Technologies) and used
as a DNA library in subsequent deep sequencing. Template
beads to be sequenced with Ion Torrent Personal Genome
Machine (Ion PGM) were prepared with the DNA library
using the Ion PGM 200 Xpress Template Kit (Applied Bio-
systems) and subjected to sequencing on Ion Torrent 314
or 316 semiconductor chip using Ion PGM 200 Sequencing
Kit (Applied Biosystems).
Deep sequencing data analysis
The host genomic sequences, located between the region
immediately adjacent to the viral 3’ LTR (ACACA) and
the linker sequence (AGATCG), were extracted from the
reads. Reads that started with GTTGGG (viral 5’ LTR)
were removed. Remaining reads were mapped to the ref-
erence genome of Macaca mulatta (MMUL 1.0) using
the Burrows-Wheeler Aligner (BWA) [53]. Reads thatwere mapped only to single sites were analyzed. In order
to obtain the absolute frequency of each provirus clone
(the number of sister cells of the clone), the end position
of each mapped read was obtained from the start pos-
ition and cigar code in the SAM file generated by BWA.
The reads with an identical start position and end pos-
ition (integration site and shear site) were judged to de-
rive from a single DNA fragment amplified by PCR,
while reads with identical integration sites but distinct
shear sites were judged to derive from different cells in a
clone. In other words, the number of reads in the second
category reflects the absolute frequency of each clone.
Relative frequency represents the proportion of the ab-
solute frequency of a clone to the number of all the sis-
ter cells observed. In order to minimize the distortion of
relative frequencies of major clones, 6,000 reads that
were mapped only to single sites were randomly selected
for each specimen and analyzed (see Additional file 2).
Treatment of STLV-1+ Japanese macaques with
humanized anti-CCR4 antibody
Two Japanese macaques infected with STLV-1 were
treated with mogamulizumab, which is an antibody
against CCR4 and is approved in Japan as a drug to treat
relapsed ATL. Mogamulizumab was provided by Kyowa
Hakko Kirin Co Ltd. One mg/kg mogamulizumab was
diluted in 40 ml saline and infused into each monkey
intravenously for 20 min. Administration was performed
once a week for 4 times. Before each administration, a
10 ml of blood sample was obtained. After the fourth
administration, blood samples were collected every 2
weeks until week 11. Extra samples were collected on
week 15 and week 18. The two monkeys were observed
for any adverse effects during the experiment.
Additional files
Additional file 1: Phylogenetic analyses of HTLV-1 subtypes and
Japanese macaque STLV-1.
Additional file 2: Deep sequencing data analysis.
Additional file 3: In vitro staining of Japanese macaque PBMCs
with mogamulizumab.
Additional file 4: Primers and oligonucleotides.
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